S
ynovial fibroblasts represent an important source of matrix degrading enzymes mediating joint destruction in rheumatoid arthritis. 1 In our search for new pathways for the activation of synovial fibroblasts we have detected endogenous retroviral sequences, like the line 1 element (L1). 2 To study the functional role of L1 we transduced synovial fibroblasts with L1 constructs and showed that L1 induces a number of crucial transcription factors for the activation of these cells. Most significant was the induction of p38 δ. At present p38 δ has not been explored in detail, although several interesting pathways have been examined. The fact that p38 δ phosphorylates various transcription factors, including ATF-2, Elk-1, and SAP-1, and that it could be shown that the ATF-2 pathway is potentially linked to the induction of certain oncogenes as well as to the production of matrix degrading metalloproteinases 3 has put this molecule at the focus of our interest.
Because inhibition of p38 α and β has been the centre of interest for new therapeutic targets by the industry we studied the expression of the different isoforms at sites of joint destruction 4 and showed that synovial cells appear to be activated not only by a cytokine dependent pathway but also by a cytokine independent pathway. The latter fact may explain the observation that anticytokine treatments of rheumatoid arthritis do not abolish joint destruction completely.
